Brazil’s researchers claim that the Sinovac vaccine is only 50% efficient

On Tuesday (January 12), researchers from Brazil have found out that China’s Sinovac vaccine that is being bought by many countries to curb COVID-19 spreads, has a low efficacy rate than announced.

During the last stage of trials in Brazil until last week, the Sinovac COVID-19 vaccine was told and was estimated by Sao Paulo researchers to have an efficacy rate of about 78%. However, this week’s data sheets have shown that patients who experienced very mild symptoms were not included in the statistics of the previous week. When the mild cases were also taken into account, the efficacy rate was brought down to just about 50.4% against mild symptoms. This means mild infections may remain.

China’s Sinovac vaccines on display | Image : Wang Zhao | AFP | Getty Images.

This new finding may affect China’s health outreach. According to¬†The New York Times, more than ten countries have already placed orders for around 380 million vaccines altogether. Malaysia and Singapore, 2 of the many countries that have placed orders, are waiting for more data to be released before they decide whether they should continue with the deal made with Sinovac. If this is the case for other countries as well, then China would fail to provide enough support and may not be able to form closer ties with other countries.

Meanwhile, Indonesia has already started its vaccination campaign with the Sinovac COVID-19 doses, with the country’s president, Mr. Joko Widodo as the first recipient of the vaccine.

Do you want to publish on Apple News, Google News, and more? Join our writing community, improve your writing skills, and be read by hundreds of thousands around the world!

More from World – News Landed

+ Sriwijaya Air’s SJ182 crashes minutes after take-off
+ Recovery principles for a country in crisis

+ House moves to Impeach the President for the second time
+ Cancer cells hibernate like a bear to tackle chemotherapy

Related Stories

Fauci feared catching COVID at Trump’s White House

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Disease and the global figurehead for the...

People unlikely to suffer from thrombocytopenia after receiving COVID-19 vaccine

The COVID-19 situation has brought the entire research communities all over the world to focus on developing vaccines. As...

Featured Stories

NASA’s Perseverance rover is set to touchdown on the Martian surface this Thursday

This February has been a good month for Mars exploration. We recently heard the news about the Emirates Mars...

Scientists want Pablo Escobar’s hippos to be killed and here’s why

We all know Pablo Escobar was one of the notorious criminals of all time. The man who lived in...

Taylor Swift announces the release of re-recorded album, ‘Fearless’; dropped a new version of ‘Love Story

On Thursday (January 11), Taylor Swift announced to the world that she would be dropping the re-recorded version of...

High altitude Arctic Lakes and their link to climate change

Most lakes around the world play a crucial role in affecting the greenhouse concentrations of the atmosphere. In extreme...

People unlikely to suffer from thrombocytopenia after receiving COVID-19 vaccine

The COVID-19 situation has brought the entire research communities all over the world to focus on developing vaccines. As...

Noise pollution has found its way to deep oceans – A research finds

When we think of pollution created by human activity, the things that come into our mind are atmospheric pollution...